Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults
- 9 January 2006
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 24 (1), 20-26
- https://doi.org/10.1016/j.vaccine.2005.08.095
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseVaccine, 2004
- A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvantVaccine, 1999
- Immune Activation by Bacterial DNA: A New Genetic CodeImmunity, 1996
- Hexamer Palindromic Oligonucleotides with 5′CG-3′ Motif(s) Induce Production of InterferonJournal of Interferon & Cytokine Research, 1996
- Bacterial DNA Induces Murine Interferon-γ Production by Stimulation of Interleukin-12 and Tumor Necrosis Factor-αCellular Immunology, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- CpG-rich islands and the function of DNA methylationNature, 1986
- Acute Hepatitis B Virus Infection: Relation of Age to the Clinical Expression of Disease and Subsequent Development of the Carrier StateThe Journal of Infectious Diseases, 1985
- Hepatitis-B Vaccination in the ElderlyThe Journal of Infectious Diseases, 1984
- Summary of worldwide clinical experience with H-B-Vax® (B, MSD)Journal of Infection, 1983